Humoral and cellular response to the COVID-19 vaccine in immunocompromised children

BACKGROUND: A suboptimal response to the 2-dose COVID-19 vaccine series in the immunocompromised population prompted recommendations for a 3rd primary dose. We aimed to determine the humoral and cellular immune response to the 3rd COVID-19 vaccine in immunocompromised children. METHODS: Prospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Morgans, Heather A., Bradley, Todd, Flebbe-Rehwaldt, Linda, Selvarangan, Rangaraj, Bagherian, Amber, Barnes, Aliessa P., Bass, Julie, Cooper, Ashley M., Fischer, Ryan, Kleiboeker, Steve, Lee, Brian R., LeMaster, Cas, Markus, Kelsey, Morrison, Stephen, Myers, Angela, Myers, Doug, Payne, Erin, Schuster, Jennifer E., Standley, Sarah, Wieser, Andrea, Warady, Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662120/
https://www.ncbi.nlm.nih.gov/pubmed/36376507
http://dx.doi.org/10.1038/s41390-022-02374-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662120/
https://www.ncbi.nlm.nih.gov/pubmed/36376507
http://dx.doi.org/10.1038/s41390-022-02374-4

Ejemplares similares